🔎 Trials Near Me

Home › Multiple Sclerosis › Maryland › Baltimore

Pag-aaral pangklinika para sa Multiple Sclerosis sa Baltimore, MD

Isang pag-aaral para sa Multiple Sclerosis ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Baltimore. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Nagre-recruitPhase 1
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT03816345

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Nagre-recruitObservasyonal na pag-aaral
  • TG Therapeutics Investigational Trial Site, Baltimore
  • TG Therapeutics Investigational Trial Site, Glen Burnie · 9 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06433752

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Nagre-recruitPhase 2
  • Sheppard Pratt, Towson · 8 mi ang layo
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07002034

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

Nagre-recruitPhase 3
  • Baltimore Veterans Affairs Medical Center- Site Number : 8400163, Baltimore
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07325292

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

Nagre-recruitPhase 2
  • Johns Hopkins University, Baltimore
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Hul 17, 2026 · NCT07497399

Solriamfetol for the Treatment of Multiple Sclerosis Fatigue

Nagre-recruitPhase 2
  • Johns Hopkins University, Baltimore
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Hun 9, 2026 · NCT06170970

Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis

Nagre-recruitPhase 4
  • Johns Hopkins University, Baltimore
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update May 6, 2026 · NCT07389590

Pag-aaral para sa Multiple Sclerosis sa ibang lungsod

Iba pang pag-aaral sa Baltimore

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.